Northern Trust’s Impact BioMedical IBO Stock Holding History
Bought
Maintained
Sold
Other funds holding IBO
Northern Trust's IBO Position: Q2 2026 in Review
Northern Trust reduced its Impact BioMedical (IBO) stake by 3.5% in Q2 2026, selling an estimated $5.01K and leaving 18,659 shares worth $108K. The position accounts for ﹤0.01% of the portfolio, ranked #4108.
Northern Trust first reported a position in IBO in Q4 2025 and has held it in 3 quarters since. The position peaked at $146K in Q1 2026. 20 funds tracked by Wall St. Rank hold IBO as of Q2 2026.
- Northern Trust held 18,659 shares of Impact BioMedical worth $108K as of Q2 2026.
- Northern Trust sold 671 Impact BioMedical shares in Q2 2026, an estimated $5.01K.
- Impact BioMedical made up ﹤0.01% of Northern Trust's portfolio in Q2 2026, its #4108 holding.
- Northern Trust first reported a position in Impact BioMedical in Q4 2025 and has held it in 3 quarters since.
- Northern Trust's Impact BioMedical position peaked at $146K in Q1 2026.
- 20 funds tracked by Wall St. Rank held Impact BioMedical as of Q2 2026.
Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.